SEC FORM 3

SEC FORM 3SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Windels Hilde

(Last)

(First)

(Middle)

CAP BUSINESS CENTER

ZONE INDUSTRIELLE DES HAUTS-SARTS

(Street)

HERSTAL

BELGIUM

4040

(City)

(State)

(Zip)

BELGIUM

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MDxHealth SA [ MDXH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Share Option	⁽¹⁾	06/01/2028	Ordinary Shares	1,000	⁽¹⁾	I	By Hilde Windels BV⁽²⁾
Share Option	⁽³⁾	07/01/2029	Ordinary Shares	1,000	⁽³⁾	I	By Hilde Windels BV⁽²⁾
Share Option	⁽⁴⁾	06/22/2034	Ordinary Shares	30,000	$2.62	I	By Hilde Windels BV⁽²⁾
Share Option	⁽⁵⁾	06/27/2035	Ordinary Shares	10,000	$2.18	I	By Hilde Windels BV⁽²⁾

Explanation of Responses:

1. Represents options to purchase 1,000 ordinary shares of the Issuer at a price per share of 49.70 Euros granted on June 1, 2018 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

2. Shares held by Hilde Windels BV may be deemed to be beneficially owned by the Reporting Person as the Managing Director of Hilde Windels BV. The Reporting Person disclaims beneficial ownership of the securities held by Hilde Windels BV other than to the extent that she may have a pecuniary interest therein.

3. Represents options to purchase 1,000 ordinary shares of the Issuer at a price per share of 12.80 Euros granted on July 1, 2019 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

4. Represents options to purchase 30,000 ordinary shares of the Issuer at a price per share of $2.62 granted on June 22, 2024 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

5. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $2.18 granted on June 27, 2025 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

	/s/ Mark Busch, as attorney-in-fact for Hilde Windels	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

SEC Form 3 filed by new insider Windels Hilde